He Huang

Dr. He Huang

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2024 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
QQQingqing Qi
Qingqing Qi
HZHuijie Zhang
Huijie Zhang
ZJZheyu Jin
Zheyu Jin
CWChangchun Wang
Changchun Wang
MXMengyu Xia
Mengyu Xia
XYXiaofei Yu
Xiaofei Yu

3 April 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
GFGuangjian Fan
Guangjian Fan
BYBo Yu
Bo Yu
LTLei Tang
Lei Tang
RZRongxuan Zhu
Rongxuan Zhu
JCJianhua Chen
Jianhua Chen
HWHongxia Wang
Hongxia Wang
Cancer-associated fibroblasts (CAFs) are abundant stromal cells in the tumor microenvironment that promote cancer progression and relapse. However, the heterogeneity and regulatory roles of CAFs underlying chemoresistance remain largely unclear. Here, we performed a single-cell analysis using high-dimensional flow cytometry analysis and identified a distinct senescence-like tetraspanin-8 (TSPAN8) + myofibroblastic CAF (myCAF) subset, which is correlated with therapeutic resistance and poor survival in multiple cohorts of patients with breast cancer (BC). TSPAN8 + myCAFs potentiate the stemness of the surrounding BC cells through secretion of senescence-associated secretory phenotype (SASP)–related factors IL-6 and IL-8 to counteract chemotherapy. NAD-dependent protein deacetylase sirtuin 6 (SIRT6) reduction was responsible for the senescence-like phenotype and tumor-promoting role of TSPAN8 + myCAFs. Mechanistically, TSPAN8 promoted the phosphorylation of ubiquitin E3 ligase retinoblastoma binding protein 6 (RBBP6) at Ser 772 by recruiting MAPK11, thereby inducing SIRT6 protein destruction. In turn, SIRT6 down-regulation up-regulated GLS1 and PYCR1 , which caused TSPAN8 + myCAFs to secrete aspartate and proline, and therefore proved a nutritional niche to support BC outgrowth. By demonstrating that TSPAN8 + SIRT6 low myCAFs were tightly associated with unfavorable disease outcomes, we proposed that the combined regimen of anti-TSPAN8 antibody and SIRT6 activator MDL-800 is a promising approach to overcome chemoresistance. These findings highlight that senescence contributes to CAF heterogeneity and chemoresistance and suggest that targeting TSPAN8 + myCAFs is a promising approach to circumvent chemoresistance.

28 February 2025 in Science
Verified
Journal Article
Closed access
KDKaixin Ding
Kaixin Ding
ZZZhipeng Zhang
Zhipeng Zhang
ZHZhengbin Han
Zhengbin Han
LSlei SHI
lei SHI
XLXinzhi Li
Xinzhi Li
ZCZheng Chen
Zheng Chen
Maintaining glucose and lipid homeostasis is crucial for health, with dysregulation leading to metabolic diseases such as type 2 diabetes mellitus (T2DM) and metabolic dysfunction–associated fatty liver disease (MAFLD). This study identifies alkylation repair homolog protein 5 (ALKBH5), an RNA N 6 -methyladenosine (m 6 A) demethylase, as a major regulator in metabolic disease. ALKBH5 is up-regulated in the liver during obesity and also phosphorylated by protein kinase A, causing its translocation to the cytosol. Hepatocyte-specific deletion of Alkbh5 reduces glucose and lipids by inhibiting the glucagon receptor (GCGR) and mammalian target of rapamycin complex 1 (mTORC1) signaling pathways. Targeted knockdown of hepatic Alkbh5 reverses T2DM and MAFLD in diabetic mice, highlighting its therapeutic potential. This study unveils a regulatory mechanism wherein ALKBH5 orchestrates glucose and lipid homeostasis by integrating the GCGR and mTORC1 pathways, providing insight into the regulation of metabolic diseases.

8 April 2019 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
Wencai ZhangWencai Zhang
Wencai Zhang
JWJulie M. Wells
Julie M. Wells
KCKin-Hoe Chow
Kin-Hoe Chow
HHHe Huang
He Huang
MYMin Yuan
Min Yuan
FSFrank J. Slack
Frank J. Slack

27 February 2023 in EMBO Molecular Medicine
Verified
Journal Article
Open access
XGXiao Guo
Xiao Guo
YZYuemeng Zhu
Yuemeng Zhu
LGLu Guo
Lu Guo
YQYiwen Qi
Yiwen Qi
XLXiaocheng Liu
Xiaocheng Liu
JLJin Li
Jin Li
Premature ovarian insufficiency (POI) is a disease featured by early menopause before 40 years of age, accompanied by an elevation of follicle‐stimulating hormone. Though POI affects many aspects of women's health, its major causes remain unknown. Many clinical studies have shown that POI patients are generally underweight, indicating a potential correlation between POI and metabolic disorders. To understand the pathogenesis of POI, we performed metabolomics analysis on serum and identified branch‐chain amino acid (BCAA) insufficiency‐related metabolic disorders in two independent cohorts from two clinics. A low BCAA diet phenotypically reproduced the metabolic, endocrine, ovarian, and reproductive changes of POI in young C57BL/6J mice. A mechanism study revealed that the BCAA insufficiency‐induced POI is associated with abnormal activation of the ceramide‐reactive oxygen species (ROS) axis and consequent impairment of ovarian granulosa cell function. Significantly, the dietary supplement of BCAA prevented the development of ROS‐induced POI in female mice. The results of this pathogenic study will lead to the development of specific therapies for POI.

2 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
LWLi Weng
Li Weng
WTWen-Shuai Tang
Wen-Shuai Tang
XWXu Wang
Xu Wang
Yingyun GongYingyun Gong
Yingyun Gong
CLChangqin Liu
Changqin Liu
TZTong-Jin Zhao
Tong-Jin Zhao
Adipocytes are the primary sites for fatty acid storage, but the synthesis rate of fatty acids is very low. The physiological significance of this phenomenon remains unclear. Here, we show that surplus fatty acid synthesis in adipocytes induces necroptosis and lipodystrophy. Transcriptional activation of FASN elevates fatty acid synthesis, but decreases NADPH level and increases ROS production, which ultimately leads to adipocyte necroptosis. We identify MED20, a subunit of the Mediator complex, as a negative regulator of FASN transcription. Adipocyte-specific male Med20 knockout mice progressively develop lipodystrophy, which is reversed by scavenging ROS. Further, in a murine model of HIV-associated lipodystrophy and a human patient with acquired lipodystrophy, ROS neutralization significantly improves metabolic disorders, indicating a causal role of ROS in disease onset. Our study well explains the low fatty acid synthesis rate in adipocytes, and sheds light on the management of acquired lipodystrophy.